Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLES
Global regulatory agencies have licensed vaccines to prevent at least 25 infectious diseases. Historically, however, new vaccines typically became available in low- and middle-income countries years (often decades) after being introduced in high-income countries. More recent initiatives have narrowed this inequity, with well-documented positive impacts on health and survival in these vulnerable populations. This White Paper discusses the World Health Organization’s Prequalification program, which has been a key contributor in overseeing the quality, safety, and suitability of vaccines used in national immunization programs.
Vaccines to prevent at least 25 infectious diseases have been licensed by global regulators. In the past, new vaccines typically became available in low- and middle income countries only years (often decades) after being introduced in high-income countries.
More recent initiatives (e.g., the Expanded Program on Immunization [EPI]) and collaborations among international organizations (e.g., The World Health Organization [WHO]; United Nations International Children’s Fund [UNICEF]; Gavi, The Vaccine Alliance) have narrowed this inequity, however, with welldocumented positive impacts on health and survival in these vulnerable populations.
A key contributor to this success has been the creation and execution of a sustainable program to oversee the quality, safety and suitability of vaccines used in national immunization programs: WHO Prequalification (WHO PQ). The WHO PQ program for vaccines was created in 1987 in order to support UNICEF and the Pan American Health Organization [PAHO] Revolving Fund, the two UN agencies primarily responsible for vaccine procurement, by providing assurance that the vaccines purchased would be consistently safe and effective under deployment conditions. In the years since its inception, the program’s processes and procedures have been revised and modified to meet evolving needs, generally at the behest of expert groups. Each revision has been endorsed or noted by the WHO Expert Committee on Biological Standardization prior to implementation and publication as part of the WHO Technical Report series or as a WHO Vaccines Department document.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Automate and standardize your regulatory management, from correspondence and commitments to registration and tracking.